Press release

Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced

articleOrthofix Medical Inc.October 25, 20224/company/orthofix-medical-inc/news/orthofix-medical-schedules-third-quarter-earnings-release-and-conference-call-for
Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022

About this update from Orthofix Medical Inc.

[{"type":"text","content":" LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it will release its third quarter 2022 financial results before market open on Thursday, November 3, 2022. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day.\n\nInterested parties may access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the event passcode 9556380. A replay of the call will be available for three weeks by dialing (800) 770-2030 in the U.S., and (647) 362-9199 in all other locations, and entering the event passcode 9556380. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com.\n\nAbout Orthofix:\n\nOrthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20221025005460/en/\n\nAlexa Huerta\nInvestor Relations\nTel 214 937 3190\[email protected]\n\nDenise Landry\nMedia Relations\nTel 214 937 2529\[email protected]\n\nSource: Orthofix Medical Inc.","length":3488,"tagName":"div"}]

More updates from Orthofix Medical Inc.